LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,210,214 | -33.0% | 53,575 | -19.4% | 0.00% | -50.0% |
| Q2 2023 | $4,792,559 | +0.4% | 66,471 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $4,772,662 | +4.9% | 66,844 | -1.8% | 0.00% | 0.0% |
| Q4 2022 | $4,549,013 | +22.5% | 68,099 | +57.9% | 0.00% | +33.3% |
| Q3 2022 | $3,714,000 | +1403.6% | 43,130 | +2602.4% | 0.00% | – |
| Q4 2021 | $247,000 | +20.5% | 1,596 | +8.3% | 0.00% | – |
| Q3 2021 | $205,000 | -92.4% | 1,474 | -93.8% | 0.00% | -100.0% |
| Q2 2019 | $2,707,000 | -10.1% | 23,716 | -1.0% | 0.00% | 0.0% |
| Q1 2019 | $3,010,000 | -22.7% | 23,946 | -16.5% | 0.00% | -25.0% |
| Q4 2018 | $3,892,000 | -46.4% | 28,684 | +8.5% | 0.00% | -42.9% |
| Q3 2018 | $7,260,000 | +42.6% | 26,449 | +7.6% | 0.01% | +40.0% |
| Q2 2018 | $5,092,000 | +29.0% | 24,580 | +2.8% | 0.01% | +25.0% |
| Q1 2018 | $3,948,000 | +43.2% | 23,907 | +18.7% | 0.00% | +33.3% |
| Q4 2017 | $2,757,000 | +39.7% | 20,133 | +39.0% | 0.00% | +50.0% |
| Q3 2017 | $1,973,000 | +10.0% | 14,488 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $1,794,000 | +0.3% | 14,780 | -12.5% | 0.00% | 0.0% |
| Q1 2017 | $1,788,000 | +19.2% | 16,894 | +14.5% | 0.00% | 0.0% |
| Q4 2016 | $1,500,000 | -4.3% | 14,758 | -3.9% | 0.00% | 0.0% |
| Q3 2016 | $1,567,000 | -82.7% | 15,355 | -79.8% | 0.00% | -80.0% |
| Q2 2016 | $9,077,000 | -2.8% | 76,108 | -12.7% | 0.01% | -9.1% |
| Q1 2016 | $9,339,000 | +4.5% | 87,203 | +5.8% | 0.01% | +10.0% |
| Q4 2015 | $8,938,000 | +21.2% | 82,441 | -4.3% | 0.01% | +11.1% |
| Q3 2015 | $7,376,000 | -5.9% | 86,116 | +10.8% | 0.01% | 0.0% |
| Q2 2015 | $7,841,000 | +8.4% | 77,708 | -17.2% | 0.01% | +12.5% |
| Q1 2015 | $7,235,000 | +26.1% | 93,833 | -13.0% | 0.01% | +33.3% |
| Q4 2014 | $5,737,000 | +33.4% | 107,812 | +17.8% | 0.01% | +20.0% |
| Q3 2014 | $4,299,000 | +655.5% | 91,493 | +901.3% | 0.01% | +400.0% |
| Q2 2014 | $569,000 | -7.5% | 9,137 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $615,000 | +151.0% | 9,137 | +96.3% | 0.00% | – |
| Q4 2013 | $245,000 | – | 4,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |